1 Market Overview

1.1 Product Overview and Scope of Nucleic Acid Drugs

1.2 Classification of Nucleic Acid Drugs by Type

1.2.1 Overview: Global Nucleic Acid Drugs Market Size by Type: 2022 Versus 2028

1.2.2 Global Nucleic Acid Drugs Revenue Market Share by Type in 2029

1.2.3 Antisense Nucleic Acid Drugs

1.2.4 siRNA Drugs

1.2.5 saRNA Drugs

1.2.6 miRNA Drugs

1.2.7 mRNA Drugs

1.2.8 other

1.3 Global Nucleic Acid Drugs Market by Application

1.3.1 Overview: Global Nucleic Acid Drugs Market Size by Application: 2023 Versus 2029

1.3.2 Genetic Disease

1.3.3 Cancer

1.3.4 Cardiovascular Diseases

1.3.5 Other

1.4 Global Nucleic Acid Drugs Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Nucleic Acid Drugs Market Drivers

1.5.2 Nucleic Acid Drugs Market Restraints

1.5.3 Nucleic Acid Drugs Trends Analysis

2 Company Profiles

2.1 Sarepta Therapeutics

2.1.1 Sarepta Therapeutics Details

2.1.2 Sarepta Therapeutics Major Business

2.1.3 Sarepta Therapeutics Nucleic Acid Drugs Product and Solutions

2.1.4 Sarepta Therapeutics Recent Developments and Future Plans

2.2 Ionis Pharmaceuticals

2.2.1 Ionis Pharmaceuticals Details

2.2.2 Ionis Pharmaceuticals Major Business

2.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Product and Solutions

2.2.4 Ionis Pharmaceuticals Recent Developments and Future Plans

2.3 Alnylam

2.3.1 Alnylam Details

2.3.2 Alnylam Major Business

2.3.3 Alnylam Nucleic Acid Drugs Product and Solutions

2.3.4 Alnylam Recent Developments and Future Plans

2.4 Mina Therapeutics

2.4.1 Mina Therapeutics Details

2.4.2 Mina Therapeutics Major Business

2.4.3 Mina Therapeutics Nucleic Acid Drugs Product and Solutions

2.4.4 Mina Therapeutics Recent Developments and Future Plans

2.5 BioNTech

2.5.1 BioNTech Details

2.5.2 BioNTech Major Business

2.5.3 BioNTech Nucleic Acid Drugs Product and Solutions

2.5.4 BioNTech Recent Developments and Future Plans

2.6 NeXstar Pharmaceuticals

2.6.1 NeXstar Pharmaceuticals Details

2.6.2 NeXstar Pharmaceuticals Major Business

2.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Product and Solutions

2.6.4 NeXstar Pharmaceuticals Recent Developments and Future Plans

2.7 Nippon Shinyaku

2.7.1 Nippon Shinyaku Details

2.7.2 Nippon Shinyaku Major Business

2.7.3 Nippon Shinyaku Nucleic Acid Drugs Product and Solutions

2.7.4 Nippon Shinyaku Recent Developments and Future Plans

2.8 Moderna Therapeutics

2.8.1 Moderna Therapeutics Details

2.8.2 Moderna Therapeutics Major Business

2.8.3 Moderna Therapeutics Nucleic Acid Drugs Product and Solutions

2.8.4 Moderna Therapeutics Recent Developments and Future Plans

2.9 CureVac

2.9.1 CureVac Details

2.9.2 CureVac Major Business

2.9.3 CureVac Nucleic Acid Drugs Product and Solutions

2.9.4 CureVac Recent Developments and Future Plans

2.10 Regulus Therapeutics

2.10.1 Regulus Therapeutics Details

2.10.2 Regulus Therapeutics Major Business

2.10.3 Regulus Therapeutics Nucleic Acid Drugs Product and Solutions

2.10.4 Regulus Therapeutics Recent Developments and Future Plans

2.11 Miragen Therapeutics

2.11.1 Miragen Therapeutics Details

2.11.2 Miragen Therapeutics Major Business

2.11.3 Miragen Therapeutics Nucleic Acid Drugs Product and Solutions

2.11.4 Miragen Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nucleic Acid Drugs Revenue and Share by Players (2023 & 2029)

3.2 Nucleic Acid Drugs Players Head Office, Products and Services Provided

3.3 Nucleic Acid Drugs Mergers & Acquisitions

3.4 Nucleic Acid Drugs New Entrants and Expansion Plans

4 Global Nucleic Acid Drugs Forecast by Region

4.1 Global Nucleic Acid Drugs Market Size by Region: 2023 VS 2029

4.2 Global Nucleic Acid Drugs Market Size by Region, (2023-2029)

4.3 North America

4.3.1 Key Companies of Nucleic Acid Drugs in North America

4.3.2 Current Situation and Forecast of Nucleic Acid Drugs in North America

4.3.3 North America Nucleic Acid Drugs Market Size and Prospect (2023-2029)

4.4 Europe

4.4.1 Key Companies of Nucleic Acid Drugs in Europe

4.4.2 Current Situation and Forecast of Nucleic Acid Drugs in Europe

4.4.3 Europe Nucleic Acid Drugs Market Size and Prospect (2023-2029)

4.5 Asia-Pacific

4.5.1 Key Companies of Nucleic Acid Drugs in Asia-Pacific

4.5.2 Current Situation and Forecast of Nucleic Acid Drugs in Asia-Pacific

4.5.3 Asia-Pacific Nucleic Acid Drugs Market Size and Prospect (2023-2029)

4.5.4 China

4.5.5 Japan

4.5.6 South Korea

4.6 South America

4.6.1 Key Companies of Nucleic Acid Drugs in South America

4.6.2 Current Situation and Forecast of Nucleic Acid Drugs in South America

4.6.3 South America Nucleic Acid Drugs Market Size and Prospect (2023-2029)

4.7 Middle East & Africa

4.7.1 Key Companies of Nucleic Acid Drugs in Middle East & Africa

4.7.2 Current Situation and Forecast of Nucleic Acid Drugs in Middle East & Africa

4.7.3 Middle East & Africa Nucleic Acid Drugs Market Size and Prospect (2023-2029)

5 Market Size Segment by Type

5.1 Global Nucleic Acid Drugs Market Forecast by Type (2023-2029)

5.2 Global Nucleic Acid Drugs Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application

6.1 Global Nucleic Acid Drugs Market Forecast by Application (2023-2029)

6.2 Global Nucleic Acid Drugs Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Nucleic Acid Drugs Revenue by Type, (USD Million), 2023 VS 2029

Table 2. Global Nucleic Acid Drugs Revenue by Application, (USD Million), 2023 VS 2029

Table 3. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors

Table 4. Sarepta Therapeutics Major Business

Table 5. Sarepta Therapeutics Nucleic Acid Drugs Product and Solutions

Table 6. Ionis Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Ionis Pharmaceuticals Major Business

Table 8. Ionis Pharmaceuticals Nucleic Acid Drugs Product and Solutions

Table 9. Alnylam Corporate Information, Head Office, and Major Competitors

Table 10. Alnylam Major Business

Table 11. Alnylam Nucleic Acid Drugs Product and Solutions

Table 12. Mina Therapeutics Corporate Information, Head Office, and Major Competitors

Table 13. Mina Therapeutics Major Business

Table 14. Mina Therapeutics Nucleic Acid Drugs Product and Solutions

Table 15. BioNTech Corporate Information, Head Office, and Major Competitors

Table 16. BioNTech Major Business

Table 17. BioNTech Nucleic Acid Drugs Product and Solutions

Table 18. NeXstar Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 19. NeXstar Pharmaceuticals Major Business

Table 20. NeXstar Pharmaceuticals Nucleic Acid Drugs Product and Solutions

Table 21. Nippon Shinyaku Corporate Information, Head Office, and Major Competitors

Table 22. Nippon Shinyaku Major Business

Table 23. Nippon Shinyaku Nucleic Acid Drugs Product and Solutions

Table 24. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors

Table 25. Moderna Therapeutics Major Business

Table 26. Moderna Therapeutics Nucleic Acid Drugs Product and Solutions

Table 27. CureVac Corporate Information, Head Office, and Major Competitors

Table 28. CureVac Major Business

Table 29. CureVac Nucleic Acid Drugs Product and Solutions

Table 30. Regulus Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Regulus Therapeutics Major Business

Table 32. Regulus Therapeutics Nucleic Acid Drugs Product and Solutions

Table 33. Miragen Therapeutics Corporate Information, Head Office, and Major Competitors

Table 34. Miragen Therapeutics Major Business

Table 35. Miragen Therapeutics Nucleic Acid Drugs Product and Solutions

Table 36. Global Nucleic Acid Drugs Revenue (USD Million) by Players (2023 & 2029)

Table 37. Global Nucleic Acid Drugs Revenue Share by Players (2023 & 2029)

Table 38. Nucleic Acid Drugs Players Head Office, Products and Services Provided

Table 39. Nucleic Acid Drugs Mergers & Acquisitions in the Past Five Years

Table 40. Nucleic Acid Drugs New Entrants and Expansion Plans

Table 41. Global Market Nucleic Acid Drugs Revenue (USD Million) Comparison by Region (2023 VS 2029)

Table 42. Global Nucleic Acid Drugs Revenue Market Share by Region (2023-2029)

Table 43. Key Companies of Nucleic Acid Drugs in North America

Table 44. Current Situation and Forecast of Nucleic Acid Drugs in North America

Table 45. Key Companies of Nucleic Acid Drugs in Europe

Table 46. Current Situation and Forecast of Nucleic Acid Drugs in Europe

Table 47. Key Companies of Nucleic Acid Drugs in Asia-Pacific

Table 48. Current Situation and Forecast of Nucleic Acid Drugs in Asia-Pacific

Table 49. Key Companies of Nucleic Acid Drugs in China

Table 50. Key Companies of Nucleic Acid Drugs in Japan

Table 51. Key Companies of Nucleic Acid Drugs in South Korea

Table 52. Key Companies of Nucleic Acid Drugs in South America

Table 53. Current Situation and Forecast of Nucleic Acid Drugs in South America

Table 54. Key Companies of Nucleic Acid Drugs in Middle East & Africa

Table 55. Current Situation and Forecast of Nucleic Acid Drugs in Middle East & Africa

Table 56. Global Nucleic Acid Drugs Revenue Forecast by Type (2023-2029)

Table 57. Global Nucleic Acid Drugs Revenue Forecast by Application (2023-2029)

List of Figures

Figure 1. Nucleic Acid Drugs Picture

Figure 2. Global Nucleic Acid Drugs Revenue Market Share by Type in 2029

Figure 3. Antisense Nucleic Acid Drugs

Figure 4. siRNA Drugs

Figure 5. saRNA Drugs

Figure 6. miRNA Drugs

Figure 7. mRNA Drugs

Figure 8. other

Figure 9. Nucleic Acid Drugs Revenue Market Share by Application in 2029

Figure 10. Genetic Disease Picture

Figure 11. Cancer Picture

Figure 12. Cardiovascular Diseases Picture

Figure 13. Other Picture

Figure 14. Global Nucleic Acid Drugs Market Size, (USD Million): 2023 VS 2029

Figure 15. Global Nucleic Acid Drugs Revenue and Forecast (2023-2029) & (USD Million)

Figure 16. Nucleic Acid Drugs Market Drivers

Figure 17. Nucleic Acid Drugs Market Restraints

Figure 18. Nucleic Acid Drugs Market Trends

Figure 19. Sarepta Therapeutics Recent Developments and Future Plans

Figure 20. Ionis Pharmaceuticals Recent Developments and Future Plans

Figure 21. Alnylam Recent Developments and Future Plans

Figure 22. Mina Therapeutics Recent Developments and Future Plans

Figure 23. BioNTech Recent Developments and Future Plans

Figure 24. NeXstar Pharmaceuticals Recent Developments and Future Plans

Figure 25. Nippon Shinyaku Recent Developments and Future Plans

Figure 26. Moderna Therapeutics Recent Developments and Future Plans

Figure 27. CureVac Recent Developments and Future Plans

Figure 28. Regulus Therapeutics Recent Developments and Future Plans

Figure 29. Miragen Therapeutics Recent Developments and Future Plans

Figure 30. Global Nucleic Acid Drugs Revenue Market Share by Region (2023-2029)

Figure 31. Global Nucleic Acid Drugs Revenue Market Share by Region in 2029

Figure 32. North America Nucleic Acid Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 33. Europe Nucleic Acid Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 34. Asia-Pacific Nucleic Acid Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 35. South America Nucleic Acid Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 36. Middle East & Africa Nucleic Acid Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 37. Global Nucleic Acid Drugs Market Share Forecast by Type (2023-2029)

Figure 38. Global Nucleic Acid Drugs Market Share Forecast by Application (2023-2029)

Figure 39. Methodology

Figure 40. Research Process and Data Source